SPRB
Spruce Biosciences, Inc.
There isn't enough reported data to score SPRB yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
SPRB Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Unavailable | |
| Unavailable |
SPRB's revenue and profitability are currently weak. There isn't enough data to rate its cash flow and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
SPRB PE Valuation
SPRB has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
SPRB Forward outlook
There aren't enough analyst estimates for SPRB to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
SPRB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$56.56 | +$29.02 |
| Q2 2026 | -$62.63 | +$24.12 |
| Q1 2026 | -$59.45 | +$40.30 |
| Q4 2025 | -$74.51 | +$22.24 |
| Q3 2025 | -$85.58 | -$15.83 |
| Q2 2025 | -$86.75 | -$10.25 |
| Q1 2025 | -$99.75 | -$15.75 |
| Q4 2024 | -$96.75 | -$3.75 |
SPRB is still losing money, but far less than before: $56.56 per share over the past year, against $147.00 at its worst in late 2022.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over SPRB on earnings quality, reporting a profit while its opponent remains loss making.
SPRB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $697K | -76% |
| Q3 2024 | $602K | -80% |
| Q2 2024 | $1.6M | -26% |
| Q1 2024 | $2M | +1.9% |
UNH has the stronger quarterly revenue trend. Revenue is down 100% for SPRB versus down 0.4% for UNH.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2024 | -3454% | -3067 points |
| Q3 2024 | -1563% | -1118 points |
| Q2 2024 | -623% | +22 points |
| Q1 2024 | -631% | +41 points |
| Q4 2023 | -387% | N/A |
| Q3 2023 | -444% | N/A |
| Q2 2023 | -645% | N/A |
| Q1 2023 | -672% | N/A |
SPRB's operating margin was −3454% last quarter, down 3067 points from the same quarter a year ago, near the bottom of its range since 2023.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
SPRB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$13.8M | -$8.4M |
| Q2 2026 | -$22.3M | -$13.4M |
| Q1 2026 | -$8.7M | +$4M |
| Q4 2025 | -$6.5M | +$14.2M |
| Q2 2025 | -$8.8M | +$2.3M |
| Q1 2025 | -$12.7M | +$2.2M |
| Q4 2024 | -$20.7M | -$9.5M |
| Q1 2024 | -$15M | -$3.2M |
SPRB has burned cash in almost every quarter: −$51M over the past year, against −$48M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over SPRB on cash generation, producing positive trailing cash flow while its opponent burns cash.
SPRB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +16% | +390K shares |
| 1 year | +377% | +2.2M shares |
| 3 years | +422% | +2.3M shares |
| 5 years | +809% | +2.5M shares |
SPRB has 3M diluted shares, up 377% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over SPRB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
SPRB Net Leverage
SPRB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
SPRB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.0 | Neutral |
| Stochastic | 27.3 | Neutral |
SPRB's weekly RSI is 42 (neutral) and its Stochastic is 27 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
SPRB PE vs Healthcare Sector
SPRB has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
SPRB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 4.5% below |
| 20 week MA | $48.4 | 11% below |
| 50 week MA | $58.4 | 27% below |
| 100 week MA | $45.9 | 6.5% below |
| 200 week MA | $86.6 | 50% below |
SPRB is in a downtrend: it's below all five of its weekly moving averages, and 50% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over SPRB on trend strength, trading above more of its moving averages.
SPRB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1,275.0 | $1,868.3 | +47% |
| 2021 | $1,868.3 | $279.0 | -85% |
| 2022 | $279.0 | $81.0 | -71% |
| 2023 | $81.0 | $219.8 | +171% |
| 2024 | $219.8 | $32.9 | -85% |
| 2025 | $32.9 | $85.7 | +161% |
| 2026 YTD | $85.7 | $42.9 | -50% |
SPRB's yearly returns have swung widely, from +171% in 2023 to −85% in 2021. It's down 50% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over SPRB on returns for 2026, with the stronger performance.